Recombinant protein experience - Blog

Efficient CHO transient transfection services for recombinant proteins and mAbs

Published on 2018-10-19 UpStream Process

CHO transient transfection

In order to provide timely production of your recombinant proteins and monoclonal antibodies, the GTP team has developed CHO-based transient transfection services using an optimized in-house protocol. In this article, you’ll learn more on how we got there: from the advantages of using a transient CHO system instead of HEK cells over the results obtained with three different CHO transient technologies to our in-house protocol and high-throughput production services.

The best process development for your protein project

Published on 2018-09-04 Process development

Process dev mAbs 2

Protein process development can be tricky. When your recombinant protein or monoclonal antibody has completed the research stage and is ready for clinical trials, you need to build a convincing preclinical package that demonstrates your project’s potential to partners and investors. To achieve this feat, you’ll want to stack all the odds in your favor to set your project up for success. Here’s some advice from GTP’s experts to help you stay on track:

GTP adds trained Biosafety Officer to expert team

Published on 2018-07-17 Corporate

Biological Safety

The production of recombinant proteins and antibodies requires specific biological and chemical agents and entails biological risks. As we know how much biosafety matters to our staff and clients, we’ve decided to train a Biological Safety Officer (BSO). Our BSO assists GTP’s technical leaders, assesses potential risks and is key to the implementation and continued application of a full-fledged biosafety policy.